National surveillance of dialysis-associated diseases in the United States, 2002 | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

National surveillance of dialysis-associated diseases in the United States, 2002

Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial. 2005;18(1):52-61.

Publication Type:

Journal Article

Authors:

Finelli, L.; Miller, J.T.; Tokars, J.I.; Alter, M.J.; Arduino, M.J.

Source:

Semin Dial, Volume 18, Issue 1, p.52-61 (2005)

Keywords:

adverse effects, Antibodies, Catheters,Indwelling, Comparative Study, Disease, epidemiology, Equipment Reuse, etiology, Georgia, Gram-Positive Bacterial Infections, HCV, Health, Hemodialysis, hepatitis, Hepatitis B, Hepatitis B Vaccines, Hepatitis B Virus, Hepatitis C, hepatitis C virus, HIV Infections, Human, Humans, Incidence, Infection, Infection Control, Kidney Failure,Chronic, medication, Methicillin Resistance, methods, microbiology, Multicenter Studies, Patient Care, Patients, Population Surveillance, Prevalence, prevention, prevention & control, Questionnaires, Renal Dialysis, standards, Surveillance, testing, therapeutic use, therapy, transmission, treatment, United States, vaccine, Vaccines, Vancomycin Resistance

Cited On:

When and in Whom to Initiate HCV Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/15663766

Export Citation:

RIS Format

Top